The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
TERT—Regulation and Roles in Cancer Formation
Open accessAbstract
Telomerase reverse transcriptase (TERT) is a catalytic subunit of telomerase. Telomerase complex plays a key role in cancer formation by telomere dependent or independent mechanisms. Telomere maintenance mechanisms include complex TERT changes such as gene amplifications, TERT structural variants, TERT promoter germline and somatic mutations, TERT epigenetic changes, and alternative lengthening of telomere. All of them are cancer specific at tissue histotype and at single cell level. TERT expression is regulated in tumors via multiple genetic and epigenetic alterations which affect telomerase activity. Telomerase activity via TERT expression has an impact on telomere length and can be a useful marker in diagnosis and prognosis of various cancers and a new therapy approach. In this review we want to highlight the main roles of TERT in different mechanisms of cancer development and regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Akiyama, M., Hideshima, T., Hayashi, T., Tai, Y., Mitsiades, C. S., Mitsiades, N., Chauhan, D., Richardson, P. G. G., Munshi, N. C., & Anderson, K. C. (2003) · PubMed · Cited by 212
RetractedBird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871 · cited 1×
“Therefore, promoters of actively transcribed genes are normally unmethylated (62).”
BackgroundWeber, M., Hellmann, I., Stadler, M. B., Ramos, L., Pääbo, S., Rebhan, M., & Schübeler, D. (2007) · Nature Genetics · doi:10.1038/ng1990 · Cited by 2,221
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Huang, F. W., Hodis, E., Xu, M. J., Kryukov, G. V., Chin, L., & Garraway, L. A. (2013) · Science · doi:10.1126/science.1229259 · Cited by 1,816
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799 · cited 1×
“They are also referred to as C228T and C250T, respectively (27, 28).”
BackgroundKillela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368
The role of STATs in transcriptional control and their impact on cellular function
Bromberg, J., & Darnell, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203476 · Cited by 1,201
Alternative lengthening of telomeres: models, mechanisms and implications
Cesare, A. J., & Reddel, R. R. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2763 · Cited by 1,035
Identification of seven loci affecting mean telomere length and their association with disease
CARDIoGRAM consortium, Codd, V., Nelson, C. P., Albrecht, E., Mangino, M., Deelen, J., Buxton, J. L., Hottenga, J. J., Fischer, K., Esko, T., et al. (2013) · Nature Genetics · doi:10.1038/ng.2528 · Cited by 933
Frequency of TERT promoter mutations in human cancers
Vinagre, J., Almeida, A., Pópulo, H., Batista, R., Lyra, J., Pinto, V., Coelho, R., Celestino, R., Prazeres, H., Lima, L., et al. (2013) · Nature Communications · doi:10.1038/ncomms3185 · Cited by 898
Human Telomerase and Its Regulation
Cong, Y.-S., Wright, W. E., & Shay, J. W. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.3.407-425.2002 · Cited by 898
Direct activation of TERT transcription by c-MYC
Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R. (1999) · Nature Genetics · doi:10.1038/6010 · Cited by 893
Complex landscapes of somatic rearrangement in human breast cancer genomes
Stephens, P. J., McBride, D. J., Lin, M.-L., Varela, I., Pleasance, E. D., Simpson, J. T., Stebbings, L. A., Leroy, C., Edkins, S., Mudie, L. J., et al. (2009) · Nature · doi:10.1038/nature08645 · Cited by 845
Intragenic DNA methylation prevents spurious transcription initiation
Neri, F., Rapelli, S., Krepelova, A., Incarnato, D., Parlato, C., Basile, G., Maldotti, M., Anselmi, F., & Oliviero, S. (2017) · Nature · doi:10.1038/nature21373 · Cited by 739
Xing, M., Liu, R., Liu, X., Murugan, A. K., Zhu, G., Zeiger, M. A., Pai, S., & Bishop, J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.5094 · Cited by 725
Telomerase modulates Wnt signalling by association with target gene chromatin
Park, J.-I., Venteicher, A. S., Hong, J. Y., Choi, J., Jun, S., Shkreli, M., Chang, W., Meng, Z., Cheung, P., Ji, H., et al. (2009) · Nature · doi:10.1038/nature08137 · Cited by 707 · cited 1×
“While telomere lengthening is considered amajor functionof telomerase, it can also modulate expression of various genes, such as nuclear factor klight-chain-enhancer of activated B cells (NF-kB) and Wnt/bcatenin signaling pathway genes (13, 14).”
BackgroundDynamic DNA methylation across diverse human cell lines and tissues
Varley, K. E., Gertz, J., Bowling, K. M., Parker, S. L., Reddy, T. E., Pauli-Behn, F., Cross, M. K., Williams, B. A., Stamatoyannopoulos, J. A., Crawford, G. E., et al. (2013) · Genome Research · doi:10.1101/gr.147942.112 · Cited by 704
Nault, J. C., Mallet, M., Pilati, C., Calderaro, J., Bioulac-Sage, P., Laurent, C., Laurent, A., Cherqui, D., Balabaud, C., & Zucman-Rossi, J. (2013) · Nature Communications · doi:10.1038/ncomms3218 · Cited by 695
Systematic analysis of telomere length and somatic alterations in 31 cancer types
Barthel, F. P., Wei, W., Tang, M., Martinez-Ledesma, E., Hu, X., Amin, S. B., Akdemir, K. C., Seth, S., Song, X., Wang, Q., et al. (2017) · Nature Genetics · doi:10.1038/ng.3781 · Cited by 614 · cited 2×
“Furthermore, a major study specifically focusing onTERT gene amplification found it to occur in many cancers, such as esophageal, ovarian cancer, and squamous cell carcinoma (12).”
BackgroundSequence variants at the TERT-CLPTM1L locus associate with many cancer types
Rafnar, T., Sulem, P., Stacey, S. N., Geller, F., Gudmundsson, J., Sigurdsson, A., Jakobsdottir, M., Helgadottir, H., Thorlacius, S., Aben, K. K. H., et al. (2009) · Nature Genetics · doi:10.1038/ng.296 · Cited by 609
Kilian, A., Bowtell, D. D. L., Abud, H. E., Hime, G. R., Venter, D. J., Keese, P. K., Duncan, E. L., Reddel, R. R., & Jefferson, R. A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2011 · Cited by 585
Yan, H., Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou206.18 · Cited by 529
Study, A. C., Bojesen, S. E., Study, A. O. C., Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), (GENICA), G. E. I. A. B. C., (SWE-BRCA), S. B. C. S., The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), (EMBRACE), E. S. O. B. &. B. M. C., (GEMO), G. M. O. C. R. I. B. M. C., Pooley, K. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2566 · Cited by 528
Albertson, D. G. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.06.007 · Cited by 527
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
Xing, M., Alzahrani, A. S., Carson, K. A., Shong, Y. K., Kim, T. Y., Viola, D., Elisei, R., Bendlová, B., Yip, L., Mian, C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.8253 · Cited by 523
Ulaner, G. A., Hu, J., Vu, T. H., Giudice, L. C., & Hoffman, A. R. (1998) · PubMed · Cited by 495
高倉, 正. (2002) · Medical Entomology and Zoology · Cited by 475
Farrell, A. S., & Sears, R. C. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014365 · Cited by 468
Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins
Martínez, P., & Blasco, M. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3025 · Cited by 468
Yuan, X., Larsson, C., & Xu, D. (2019) · Oncogene · doi:10.1038/s41388-019-0872-9 · Cited by 450
Metabolic Regulation by p53 Family Members
Berkers, C. R., Maddocks, O. D. K., Cheung, E. C., Mor, I., & Vousden, K. H. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.019 · Cited by 446
Telomerase directly regulates NF-κB-dependent transcription
Ghosh, A., Saginc, G., Leow, S. C., Khattar, E., Shin, E. M., Yan, T. D., Wong, M., Zhang, Z., Li, G., Sung, W.-K., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2621 · Cited by 378 · cited 1×
“While telomere lengthening is considered amajor functionof telomerase, it can also modulate expression of various genes, such as nuclear factor klight-chain-enhancer of activated B cells (NF-kB) and Wnt/bcatenin signaling pathway genes (13, 14).”
BackgroundRachakonda, P. S., Hosen, I., de Verdier, P. J., Fallah, M., Heidenreich, B., Ryk, C., Wiklund, N. P., Steineck, G., Schadendorf, D., Hemminki, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310522110 · Cited by 340
Xu, D., Popov, N., Hou, M., Wang, Q., Björkholm, M., Gruber, A., Menkel, A. R., & Henriksson, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071043198 · Cited by 325
Novel anticancer therapeutics targeting telomerase
Ruden, M., & Puri, N. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.06.007 · Cited by 310
Telomeres and Telomere Length: A General Overview
Srinivas, N., Rachakonda, S., & Kumar, R. (2020) · Cancers · doi:10.3390/cancers12030558 · Cited by 304
Liu, R., Bishop, J., Zhu, G., Zhang, T., Ladenson, P. W., & Xing, M. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3288 · Cited by 296
Wick, M., Zubov, D., & Hagen, G. (1999) · Gene · doi:10.1016/s0378-1119(99)00108-0 · Cited by 280
Chiba, K., Lorbeer, F. K., Shain, A. H., McSwiggen, D. T., Schruf, E., Oh, A., Ryu, J., Darzacq, X., Bastian, B. C., & Hockemeyer, D. (2017) · Science · doi:10.1126/science.aao0535 · Cited by 276
Regulation of the human catalytic subunit of telomerase (hTERT)
Daniel, M., Peek, G. W., & Tollefsbol, T. O. (2012) · Gene · doi:10.1016/j.gene.2012.01.095 · Cited by 266
Splice variants as cancer biomarkers
Brinkman, B. M. N. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.05.015 · Cited by 265
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
Leão, R., Apolónio, J. D., Lee, D., Figueiredo, A., Tabori, U., & Castelo-Branco, P. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0422-8 · Cited by 265
Killela, P. J., Pirozzi, C. J., Healy, P., Reitman, Z. J., Lipp, E., Rasheed, B. A., Yang, R., Diplas, B. H., Wang, Z., Greer, P. K., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1765 · Cited by 263
Guilleret, I., Yan, P., Grange, F., Braunschweig, R., Bosman, F. T., & Benhattar, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10593 · Cited by 260 · cited 1×
“Promotermethylation is also amajor regulatory element ofTERT expression, correlating bothwithTERTmRNA levels and telomerase activity (66).”
BackgroundKinde, I., Munari, E., Faraj, S. F., Hruban, R. H., Schoenberg, M., Bivalacqua, T., Allaf, M., Springer, S., Wang, Y., Diaz, L. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2498 · Cited by 253
The p53 family: guardians of maternal reproduction
Levine, A. J., Tomasini, R., McKeon, F. D., Mak, T. W., & Melino, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3086 · Cited by 252
Cancer-associated TERT promoter mutations abrogate telomerase silencing
Chiba, K., Johnson, J. Z., Vogan, J. M., Wagner, T., Boyle, J. M., & Hockemeyer, D. (2015) · eLife · doi:10.7554/elife.07918 · Cited by 251
Castelo-Branco, P., Choufani, S., Mack, S., Gallagher, D., Zhang, C., Lipman, T., Zhukova, N., Walker, E. J., Martin, D., Merino, D., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70110-4 · Cited by 250
Zhang, X., Xu, L., & Wang, F. (2017) · Cell Biology International · doi:10.1002/cbin.10826 · Cited by 241
The hTERTα Splice Variant is a Dominant Negative Inhibitor of Telomerase Activity
Colgin, L. M., Wilkinso, C., Englezou, A., Kilian, A., Robinson, M. O., & Reddel, R. R. (2000) · Neoplasia · doi:10.1038/sj.neo.7900112 · Cited by 229
Telomerase at the intersection of cancer and aging
Bernardes de Jesus, B., & Blasco, M. A. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.06.007 · Cited by 227
Reactivation of telomerase in cancer
Akincilar, S. C., Unal, B., & Tergaonkar, V. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2146-9 · Cited by 222
The Spemann organizer gene, Goosecoid , promotes tumor metastasis
Hartwell, K. A., Muir, B., Reinhardt, F., Carpenter, A. E., Sgroi, D. C., & Weinberg, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608636103 · Cited by 220
Horikawa, I., & Barrett, J. C. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg085 · Cited by 211
Zinn, R. L., Pruitt, K., Eguchi, S., Baylin, S. B., & Herman, J. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3396 · Cited by 210
Renaud, S., Loukinov, D., Abdullaev, Z., Guilleret, I., Bosman, F. T., Lobanenkov, V., & Benhattar, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1125 · Cited by 204
Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
Li, Y., Zhou, Q.-L., Sun, W., Chandrasekharan, P., Cheng, H. S., Ying, Z., Lakshmanan, M., Raju, A., Tenen, D. G., Cheng, S.-Y., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3240 · Cited by 200
Li, S., Rosenberg, J. E., Donjacour, A. A., Botchkina, I. L., Hom, Y. K., Cunha, G. R., & Blackburn, E. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0953 · Cited by 194
DNA hypermethylation within TERT promoter upregulates TERT expression in cancer
Lee, D. D., Leão, R., Komosa, M., Gallo, M., Zhang, C. H., Lipman, T., Remke, M., Heidari, A., Nunes, N. M., Apolónio, J. D., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121303 · Cited by 183
Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress
Saretzki, G. C. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140630095606 · Cited by 175
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Ramlee, M. K., Wang, J., Toh, W. H., & Li, S. (2016) · Genes · doi:10.3390/genes7080050 · Cited by 175
Noncanonical Functions of Telomerase: Implications in Telomerase-Targeted Cancer Therapies
Li, Y., & Tergaonkar, V. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3568 · Cited by 172
Targeting telomerase for cancer therapeutics
Shay, J. W., & Keith, W. N. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604209 · Cited by 171
Rho protein GTPases and their interactions with NFκB: crossroads of inflammation and matrix biology
Tong, L., & Tergaonkar, V. (2014) · Bioscience Reports · doi:10.1042/bsr20140021 · Cited by 162
Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity
Koh, C. M., Khattar, E., Leow, S. C., Liu, C. Y., Muller, J., Ang, W. X., Li, Y., Franzoso, G., Li, S., Guccione, E., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79134 · Cited by 162
Listerman, I., Sun, J., Gazzaniga, F. S., Lukas, J. L., & Blackburn, E. H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3082 · Cited by 159
Therapeutic Targeting of Telomerase
Jäger, K., & Walter, M. (2016) · Genes · doi:10.3390/genes7070039 · Cited by 157
Telomere Maintenance Mechanisms in Cancer
Gaspar, T. B., Sá, A., Lopes, J. M., Sobrinho-Simões, M. A., Soares, P., & Vinagre, J. (2018) · Genes · doi:10.3390/genes9050241 · Cited by 156
CTCF binds the proximal exonic region of hTERT and inhibits its transcription
Renaud, S., Loukinov, D., Bosman, F. T., Lobanenkov, V., & Benhattar, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki989 · Cited by 153
Hrdličková, R., Nehyba, J., & Bose, H. R. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00550-12 · Cited by 147
Meeran, S. M., Patel, S. N., Chan, T. H., & Tollefsbol, T. O. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0009 · Cited by 146
Genetic and epigenetic modulation of telomerase activity in development and disease
Liu, L., Lai, S. R., Andrews, L. G., & Tollefsbol, T. O. (2004) · Gene · doi:10.1016/j.gene.2004.06.011 · Cited by 137
Telomerase-Targeted Cancer Immunotherapy
Mizukoshi, E., & Kaneko, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081823 · Cited by 136
Chen, L., Mh, L., Zhang, D., Hao, N.-B., Fan, Y., Wu, Y.-Y., Wang, S.-M., Xie, R., Dc, F., Zhang, H., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.553 · Cited by 133
Targeting isocitrate dehydrogenase (IDH) in cancer.
Fujii, T., Khawaja, M. R., Dinardo, C. D., Atkins, J. T., & Jankú, F. (2016) · PubMed · Cited by 133
Variation at theTERTlocus and predisposition for cancer
Baird, D. M. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239941000147x · Cited by 130
TERT promoter mutations in melanoma survival
Nagore, E., Heidenreich, B., Rachakonda, P. S., García‐Casado, Z., Requena, C., Soriano, V., Frank, C., Traves, V., Quecedo, E., Sanjuan‐Gimenez, J., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30042 · Cited by 130
MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer
Rahman, M. M., Brane, A. C., & Tollefsbol, T. O. (2019) · Cells · doi:10.3390/cells8101214 · Cited by 128
Konnikova, L., Simeone, M., Kruger, M. M., Kotecki, M., & Cochran, B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0924 · Cited by 124
Mechanisms of transcriptional regulation by WT1 (Wilms’ tumour 1)
Toska, E., & Roberts, S. G. E. (2014) · Biochemical Journal · doi:10.1042/bj20131587 · Cited by 122
Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms
Lewis, K. A., & Tollefsbol, T. O. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00083 · Cited by 122
Telomeres and telomerase in oncogenesis (Review)
Trybek, T., Kowalik, A., Góźdź, S., & Kowalska, A. (2020) · Oncology Letters · doi:10.3892/ol.2020.11659 · Cited by 119
Telomere and Telomerase Therapeutics in Cancer
Xu, Y., & Goldkorn, A. (2016) · Genes · doi:10.3390/genes7060022 · Cited by 118
Fujimoto, K., Kyo, S., Takakura, M., Kanaya, T., Kitagawa, Y., Itoh, H., Takahashi, M., & Inoue, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.13.2557 · Cited by 116
Sæbøe‐Larssen, S., Fossberg, E., & Gaudernack, G. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-26 · Cited by 115
Kovalenko, O. A., Caron, M. J., Ulema, P., Medrano, C., Thomas, A. P., Kimura, M., Bonini, M. G., Herbig, U., & Santos, J. H. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00551.x · Cited by 115
Treating Cancer by Targeting Telomeres and Telomerase
Ivancich, M., Schrank, Z., Wojdyla, L. M., Leviskas, B., Kuckovic, A., Sanjali, A., & Puri, N. (2017) · Antioxidants · doi:10.3390/antiox6010015 · Cited by 111
Telomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondria
Chiodi, I., & Mondello, C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00133 · Cited by 109
Ryan, S. D., Britigan, E. M. C., Zasadil, L. M., Witte, K., Audhya, A., Roopra, A., & Weaver, B. A. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201911109 · Cited by 108
TERT biology and function in cancer: beyond immortalisation
Pestana, A., Vinagre, J., Sobrinho-Simões, M. A., & Soares, P. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0195 · Cited by 108
Chai, L., Kang, X., Sun, Z., Zeng, M., Yu, S., Ding, Y., Liang, J., Li, T., & Zhao, J. (2018) · Cancer Management and Research · doi:10.2147/cmar.s163335 · Cited by 107
Aylon, Y., & Oren, M. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.002 · Cited by 106
Non-canonical Roles of Telomerase: Unraveling the Imbroglio
Ségal-Bendirdjian, E., & Géli, V. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00332 · Cited by 106
Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer
Hosen, M. I., Rachakonda, P. S., Heidenreich, B., de Verdier, P. J., Ryk, C., Steineck, G., Hemminki, K., & Kumar, R. (2015) · International Journal of Cancer · doi:10.1002/ijc.29526 · Cited by 105
TERT promoter mutations and monoallelic activation of TERT in cancer
Huang, F. W., Bielski, C. M., Rinne, M. L., Hahn, W. C., Sellers, W. R., Stegmeier, F. P., Garraway, L. A., & Kryukov, G. V. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.39 · Cited by 103
Functional role of post-translational modifications of Sp1 in tumorigenesis
Chang, W., & Hung, J. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-94 · Cited by 102
Serrano, D., Bleau, A., Fernandez‐Garcia, I., Fernández‐Marcelo, T., Iniesta, P., Ortíz-de-Solórzano, C., & Calvo, A. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-96 · Cited by 99
Understanding the Role of the Transcription Factor Sp1 in Ovarian Cancer: from Theory to Practice
Vellingiri, B., Iyer, M., Subramaniam, M. D., Jayaramayya, K., Siama, Z., Giridharan, B., Narayanasamy, A., Dayem, A. A., & Cho, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031153 · Cited by 97
Telomerase regulation at the crossroads of cell fate
Ćukušić, A., Vidaček, N. Š., Sopta, M., & Rubelj, I. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167812 · Cited by 93
Leao, R. R. N., Lee, D., Figueiredo, A., Hermanns, T., Wild, P. J., Komosa, M., Lau, I., Mistry, M., Nunes, N. M., Price, A. J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31935 · Cited by 93
Eozénou, C., Gonen, N., Touzón, M. S., Jørgensen, A., Yatsenko, S. A., Fusée, L. T. S., Kamel, A. K., Gellén, B., Guercio, G., Singh, P., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921676117 · Cited by 91
Stern, J. L., Paucek, R. D., Huang, F. W., Ghandi, M., Nwumeh, R., Costello, J. C., & Cech, T. R. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.12.001 · Cited by 81
Expression Profile of a γ-Deletion Variant of the Human Telomerase Reverse Transcriptase Gene
Hisatomi, H., Ohyashiki, K., Ohyashiki, J. H., Nagao, K., Kanamaru, T., Hirata, H., Hibi, N., & Tsukada, Y. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80051-9 · Cited by 77
Castelo‐Branco, P., Leao, R. R. N., Lipman, T., Campbell, B. B., Lee, D., Price, A. J., Zhang, C., Heidari, A., Stephens, D., Boerno, S. T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10639 · Cited by 77
Mitochondrial Dysfunction in Aging and Cancer
Moro, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111983 · Cited by 76
Wang, L., Soria, J., Chang, Y. S., Lee, H., Wei, Q., & Mao, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206852 · Cited by 74
Current Insights to Regulation and Role of Telomerase in Human Diseases
Ozturk, M. B., Li, Y., & Tergaonkar, V. (2017) · Antioxidants · doi:10.3390/antiox6010017 · Cited by 73
Seynnaeve, B. K. N., Lee, S., Borah, S., Park, Y., Pappo, A. S., Kirkwood, J. M., & Bahrami, A. (2017) · Scientific Reports · doi:10.1038/srep45704 · Cited by 73
DNA methylation of the TERT promoter and its impact on human cancer
Lee, D. D., Komosa, M., Nunes, N. M., & Tabori, U. Y. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.02.003 · Cited by 73
Deng, W., Jayachandran, G., Wu, G., Xu, K., Roth, J. A., & Ji, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610579200 · Cited by 72
The non-canonical functions of telomerase: to turn off or not to turn off
Romaniuk-Drapała, A., Paszel-Jaworska, A., Totoń, E., Lisiak, N., Hołysz, H., Królak, A., Grodecka-Gazdecka, S., & Rubiś, B. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4496-x · Cited by 71
Implications of telomere‐independent activities of telomerase reverse transcriptase in human cancer
Ding, D., Zhou, J., Wang, M., & Cong, Y. (2013) · FEBS Journal · doi:10.1111/febs.12258 · Cited by 70
Vuong, H. G., Altibi, A. M. A., Duong, U. N. P., Ngo, H. T. T., Pham, T. Q., Chan, A. K., Park, C., Fung, K.-M. A., & Hassell, L. A. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.09.013 · Cited by 68
miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells
Ohira, T., Sunamura, N., Nakayama, Y., Osaki, M., Okada, F., Oshimura, M., & Kugoh, H. (2015) · Scientific Reports · doi:10.1038/srep08201 · Cited by 67
Fan, Y., Liu, Z., Fang, X., Ge, Z., Ge, N., Jia, Y., Sun, P., Lou, F., Björkholm, M., Gruber, A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0099 · Cited by 66
Wei, C.-W., Lin, C.-C., Yu, Y.-L., Lin, P.-C., Lin, P.-C., Wu, M.-T., Chen, C.-J., Chang, W., Lin, S.-Z., Chen, Y.-L. S., et al. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.124 · Cited by 66
Telomerase: Key regulator of inflammation and cancer
Wu, L., Fidan, K., Um, J., & Ahn, K. S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104726 · Cited by 66
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
George, S. L., Parmar, V. S., Lorenzi, F., Marshall, L. V., Jamin, Y., Poon, E., Angelini, P., & Chesler, L. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01582-2 · Cited by 64
Replication Stress at Telomeric and Mitochondrial DNA: Common Origins and Consequences on Ageing
Billard, P., & Poncet, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194959 · Cited by 63
Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis
Mosrati, M. A., Willander, K., Falk, I. J., Hermanson, M., Höglund, M., Stockelberg, D., Wei, Y., Lotfi, K., & Söderkvist, P. (2015) · Oncotarget · doi:10.18632/oncotarget.4668 · Cited by 61
POT1-TPP1 telomere length regulation and disease
Aramburu, T. M., Plucinsky, S. M., & Skordalakes, E. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.06.040 · Cited by 61
TERT promoter mutations in clear cell renal cell carcinoma
Hosen, M. I., Rachakonda, P. S., Heidenreich, B., Sitaram, R. T., Ljungberg, B., Roos, G., Hemminki, K., & Kumar, R. (2014) · International Journal of Cancer · doi:10.1002/ijc.29279 · Cited by 59
Wang, N., Kjellin, H., Sofiadis, A., Fotouhi, O., Juhlin, C. C., Bäckdahl, M., Zedenius, J., Xu, D., Lehtiö, J., & Larsson, C. (2016) · Oncotarget · doi:10.18632/oncotarget.7237 · Cited by 58
TERT promoter mutation subtypes and survival in stage I and II melanoma patients
Lencina, J. J. A., Rachakonda, P. S., García‐Casado, Z., Srinivas, N., Skorokhod, A., Requena, C., Soriano, V., Kumar, R., & Nagore, E. (2018) · International Journal of Cancer · doi:10.1002/ijc.31780 · Cited by 58
MAD1 and its life as a MYC antagonist: An update
Lüscher, B. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.07.005 · Cited by 56
Chau, M. N., Touny, L. H. E., Jagadeesh, S., & Banerjee, P. P. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm148 · Cited by 56
DNA Cytosine Methylation and Hydroxymethylation at the Borders
Ehrlich, M., & Ehrlich, K. C. (2014) · Epigenomics · doi:10.2217/epi.14.48 · Cited by 55
Kumari, A., Srinivasan, R., Vasishta, R. K., & Wig, J. D. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0333-8 · Cited by 55
Differential Protein Distribution between the Nucleus and Mitochondria: Implications in Aging
Lionaki, E., Gkikas, I., & Tavernarakis, N. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00162 · Cited by 55
Krams, M., Hero, B., Berthold, F., Parwaresch, R. M., Harms, D., & Rudolph, P. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63896-5 · Cited by 54
Oligonucleotides Targeting Telomeres and Telomerase in Cancer
Schrank, Z., Khan, N. H., Osude, C., Singh, S., Miller, R. J., Merrick, C., Mabel, A., Kuckovic, A., & Puri, N. (2018) · Molecules · doi:10.3390/molecules23092267 · Cited by 54
Gay‐Bellile, M., Véronèse, L., Combes, P., Eymard-Pierre, É., Kwiatkowski, F., Dauplat, M.-M., Cayre, A., Privat, M., Abrial, C., Bignon, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20560 · Cited by 52
Targeting DNA-PKcs and telomerase in brain tumour cells
Gurung, R. L., Lim, H. K., Venkatesan, S., Lee, P. S. W., & Hande, M. P. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-232 · Cited by 50
Jäger, R., Harutyunyan, A. S., Rumi, E., Pietra, D., Berg, T., Olcaydu, D., Houlston, R. S., Cazzola, M., & Královics, R. (2014) · American Journal of Hematology · doi:10.1002/ajh.23842 · Cited by 49
Yamada, O., & Kawauchi, K. (2013) · JAK-STAT · doi:10.4161/jkst.25256 · Cited by 48
Human Specific Regulation of the Telomerase Reverse Transcriptase Gene
Zhang, F., Cheng, D., Wang, S., & Zhu, J. (2016) · Genes · doi:10.3390/genes7070030 · Cited by 48
TERT promoter hotspot mutations in breast cancer
Shimoi, T., Yoshida, M., Kitamura, Y., Yoshino, T., Kawachi, A., Shimomura, A., Noguchi, E., Yunokawa, M., Yonemori, K., Shimizu, C., et al. (2017) · Breast Cancer · doi:10.1007/s12282-017-0825-5 · Cited by 48
Vaccination of patients with cutaneous melanoma with telomerase-specific peptides
Hunger, R. E., Lang, K. K., Markowski-Grimsrud, C. J., Trachsel, S., Møller, M., Eriksen, J. A., Rasmussen, A., Braathen, L. R., & Gaudernack, G. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1061-z · Cited by 47
Rowland, T. J., Dumbović, G., Hass, E. P., Rinn, J. L., & Cech, T. R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908275116 · Cited by 47
Sensitive and rapid detection ofTERTpromoter andIDHmutations in diffuse gliomas
Diplas, B. H., Liu, H., Yang, R. R., Hansen, L. J., Zachem, A. L., Zhao, F., Bigner, D. D., McLendon, R. E., Jiao, Y., He, Y., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy167 · Cited by 45
Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-Cancer Cells MCF7 and MDA-MB-231
Konieczna, N., Romaniuk-Drapała, A., Lisiak, N., Totoń, E., Paszel-Jaworska, A., Kaczmarek, M., & Rubiś, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112670 · Cited by 45
Wang, N., Xu, D., Sofiadis, A., Höög, A., Vukojević, V. B., Bäckdahl, M., Zedenius, J., & Larsson, C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1158 · Cited by 44
Frequency of TERT Promoter Mutations in Prostate Cancer
Stoehr, R., Taubert, H. W., Zinnall, U., Giedl, J., Gaisa, N. T., Burger, M., Ruemmele, P., Hurst, C. D., Knowles, M. A., Wullich, B., et al. (2015) · Pathobiology · doi:10.1159/000381903 · Cited by 43
Bacterial and viral vectors as vaccine delivery vehicles for breast cancer therapy
Shanmugaraj, B., Priya, L. B., Mahalakshmi, B., Subbiah, S., Hu, R., Velmurugan, B. K., & Baskaran, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117550 · Cited by 43
Recurrent TERT promoter mutations in non-small cell lung cancers
Ma, X., Gong, R., Wang, R., Pan, Y., Cai, D., Pan, B., Li, Y., Xiang, J., Li, H., Zhang, J., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.10.009 · Cited by 42
Saraswati, A. P., Relitti, N., Brindisi, M., Gemma, S., Zisterer, D. M., Butini, S., & Campiani, G. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.015 · Cited by 42
Telomerase based anticancer immunotherapy and vaccines approaches
Kailashiya, C., Sharma, H. B., & Kailashiya, J. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.011 · Cited by 40
Li, P., Wang, Z., Chu, I.-T., Kuan, Y.-M., Li, M., Huang, M.-C., Chiang, P.-C., Chang, T., & Chen, C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.808022 · Cited by 40
Trifa, A., Bănescu, C., Tevet, M., Bojan, A., Dima, D., Urian, L., Török-Vistai, T., Popov, V., Zdrenghea, M., Petrov, L., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14041 · Cited by 39
KANG, K.-W., LEE, M.-J., Song, J.-A., JEONG, J.-Y., KIM, Y.-K., Lee, C. M., Kim, T., KWAK, K.-B., Kim, O.-J., & An, H. J. (2014) · Oncology Reports · doi:10.3892/or.2014.3203 · Cited by 38
Mad1 destabilizes p53 by preventing PML from sequestering MDM2
Wan, J., Block, S., Scribano, C. M., Thiry, R., Esbona, K., Audhya, A., & Weaver, B. A. A. (2019) · Nature Communications · doi:10.1038/s41467-019-09471-9 · Cited by 38
Diverse regulatory manners of human telomerase reverse transcriptase
Jie, M., Chang, X., Zeng, S., Liu, C., Liao, G., Wu, Y., Liu, C., Hu, C.-J., Yang, S., & Li, X. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0372-0 · Cited by 38
DNA Copy Number Variations as Markers of Mutagenic Impact
Hovhannisyan, G. G., Harutyunyan, T. A., Aroutiounian, R. M., & Liehr, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194723 · Cited by 38
Identification ofIDHandTERTpmutation status using1H‐MRS in 112 hemispheric diffuse gliomas
Öztürk-Işık, E., Cengiz, S. D., Özcan, A., Yakıcıer, C., Danyeli, A. E., Pamir, M. N., Özduman, K., & Dinçer, A. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26964 · Cited by 38
Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one
Fenoglio, D., Parodi, A., Lavieri, R., Kalli, F., Ferrera, F., Tagliamacco, A., Guastalla, A., Lamperti, G., Giacomini, M. L., & Filaci, G. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1012032 · Cited by 37
Medical genetics and epigenetics of telomerase
Koziel, J. E., Fox, M. J., Steding, C. E., Sprouse, A. A., & Herbert, B. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01276.x · Cited by 37
Telomerase and its extracurricular activities
Jaiswal, R. K., Kumar, P., & Yadava, P. K. (2013) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-013-0105-0 · Cited by 36
Endoplasmic reticulum stress activates telomerase
Zhou, J., Mao, B., Zhou, Q., Ding, D., Wang, M., Guo, P., Gao, Y., Shay, J. W., Yuan, Z., & Cong, Y. (2013) · Aging Cell · doi:10.1111/acel.12161 · Cited by 36
Shen, N., Lu, Y., Wang, X., Peng, J., Zhu, Y., & Cheng, L. (2017) · Oncotarget · doi:10.18632/oncotarget.15140 · Cited by 36
miR-128 inhibits telomerase activity by targeting TERT mRNA
Guzman, H., Sanders, K. J., Idica, A., Bochnakian, A., Jury, D., Daugaard, I., Zisoulis, D. G., & Pedersen, I. M. (2018) · Oncotarget · doi:10.18632/oncotarget.24284 · Cited by 36
Copy Number Variations in Adult-onset Neuropsychiatric Diseases
Lew, A. R., Kellermayer, T. R., Sule, B. P., & Szigeti, K. (2018) · Current Genomics · doi:10.2174/1389202919666180330153842 · Cited by 36
Hao, Y., Yang, X., Chen, C., YuanWang, Wang, X., Li, M., & Yu, Z. (2010) · International Journal of Radiation Biology · doi:10.3109/09553000903264507 · Cited by 34
Snetselaar, R., van Oosterhout, M. F. M., Grutters, J. C., & van Moorsel, C. H. M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00041 · Cited by 34
Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma
Panero, J., Alves‐Paiva, R. M., Roisman, A., Santana-Lemos, B. A. A., Falcão, R. P., Oliveira, G., Pereira‐Martins, D. A., Stanganelli, C., Slavutsky, I. R., & Calado, R. T. (2016) · American Journal of Hematology · doi:10.1002/ajh.24324 · Cited by 33
Wu, Y., Ou, C., Chien, P., Chang, H. H., Ko, J., & Wang, B. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.218 · Cited by 33
Li, L., Gao, Y., Wu, Q., Cheng, A. S. L., & Yip, K. Y.-L. (2019) · Genome Research · doi:10.1101/gr.240036.118 · Cited by 33
Ameri, Z., Ghiasi, S., Farsinejad, A., Hassanshahi, G., Ehsan, M., & Fatemi, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.060 · Cited by 32
Chen, R., Ding, H. J., Yan, F., Zhou, L., Ji, X.-H., Gu, X.-N., & Tang, Z. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s60760 · Cited by 31
Salgado, C., Roelse, C. M., Nell, R. J., Gruis, N. A., van Doorn, R., & van der Velden, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231418 · Cited by 31
Dissecting the non-canonical functions of telomerase
Parkinson, E. K., Fitchett, C., & Cereser, B. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167813 · Cited by 30
TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population
Yoo, S. S., Do, S. K., Choi, J. E., Lee, S. Y., Lee, J., Ick, S., Kim, C. H., & Park, J. Y. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.10.1423 · Cited by 30
Telomerase inhibitors: a patent review (2010–2015)
Man, R., Chen, L., & Zhu, H. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1181172 · Cited by 30
Avin, B. A., Wang, Y., Gilpatrick, T., Workman, R. E., Lee, I., Timp, W., Umbricht, C. B., & Zeiger, M. A. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22735 · Cited by 30
Farina, A. N., Faiola, F., & Martinez, E. (2004) · Protein Expression and Purification · doi:10.1016/j.pep.2003.11.021 · Cited by 29
Telomerase Reverse Transcriptase Regulates microRNAs
Lassmann, T., Maida, Y., Tomaru, Y., Yasukawa, M., Ando, Y., Kojima, M., Kasim, V., Simon, C., Daub, C. O., Carninci, P., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16011192 · Cited by 27
MAD1: Kinetochore Receptors and Catalytic Mechanisms
Luo, Y., Ahmad, E., & Liu, S. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00051 · Cited by 27
E2F1 acts as a negative feedback regulator of c-Myc-induced hTERT transcription during tumorigenesis
Zhang, Y., Zhang, A., Shen, C., Zhang, B., RAO, Z., Wang, R., Yang, S., Ning, S., Mao, G.-P., & Fang, D.-C. (2014) · Oncology Reports · doi:10.3892/or.2014.3287 · Cited by 26
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma
Maturo, M. G., Rachakonda, P. S., Heidenreich, B., Pellegrini, C., Srinivas, N., Requena, C., Serra-Guillén, C., Llombart, B., Sanmartín, O., Guillén, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65057-2 · Cited by 26
Wysoczańska, B., Dratwa, M., Gębura, K., Mizgala, J., Mazur, G. J., Wróbel, T., & Bogunia‐Kubik, K. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s198313 · Cited by 25
Self-citationMcKelvey, B. A., Gilpatrick, T., Wang, Y., Timp, W., Umbricht, C. B., & Zeiger, M. A. (2020) · Thyroid · doi:10.1089/thy.2020.0055 · Cited by 25
Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma
Kim, Y. S., Kim, K., Kwon, G.-Y., Lee, S. J., & Park, S. H. (2018) · BMC Urology · doi:10.1186/s12894-018-0380-1 · Cited by 23
Amor, S., Rémy, S., Dambrine, G., Vern, Y. L., Rasschaert, D., & Laurent, S. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-571 · Cited by 22
Zheng, L., Suzuki, H., Nakajo, Y., Nakano, A., & Kato, M. (2017) · Cancer Science · doi:10.1111/cas.13466 · Cited by 22
Lack of TERT Promoter Mutations in Human B-Cell Non-Hodgkin Lymphoma
Lam, G., Xian, R. R., Li, Y., Burns, K. H., & BEEMON, K. L. (2016) · Genes · doi:10.3390/genes7110093 · Cited by 20
Losi, L., Lauriola, A., Tazzioli, E., Gozzi, G., Scurani, L., D’Arca, D., & Benhattar, J. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0536-y · Cited by 19
In silico design of telomerase inhibitors
Bagiński, M., & Serbakowska, K. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.024 · Cited by 19
Palma, M., Parker, A. E., Hojjat‐Farsangi, M., Forster, J., Kokhaei, P., Hansson, L., Österborg, A., & Mellstedt, H. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.03.008 · Cited by 18
Hotspot TERT promoter mutations are rare events in testicular germ cell tumors
Cárcano, F. M., Vidal, D. O., Lengert, A. V. H., Scapulatempo‐Neto, C., Queiroz, L., Marques, H., Baltazar, F., Martinelli, C. M. D. S., Soares, P., da Silva, E. C. A., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4317-y · Cited by 17
Fujiki, T., Udono, M., Kadooka, K., Yamashita, S., Miura, T., Shirahata, S., & Katakura, Y. (2010) · Cytotechnology · doi:10.1007/s10616-010-9276-y · Cited by 15
Nassir, N., Hyde, G. J., & Baskar, R. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008188 · Cited by 14
Ogawa, H., Murayama, A., Nagata, S., & Fukunaga, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207615200 · Cited by 13
Dratwa, M., Wysoczańska, B., Turlej, E., Anisiewicz, A., Maciejewska, M., Wietrzyk, J., & Bogunia‐Kubik, K. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112298 · Cited by 13
Self-citationTelomeres and telomerase in oncogenesis
Kowalska, A., & Kowalik, A. (2006) · Contemporary Oncology/Współczesna Onkologia · Cited by 12
Vinothkumar, V., Arun, K., Arunkumar, G., Revathidevi, S., Ramani, R., Bhaskar, L. V., Murugan, A. K., & Munirajan, A. K. (2020) · Molecular and Clinical Oncology · doi:10.3892/mco.2020.2003 · Cited by 12
de Haas, N., de Koning, C. C. H., Blasio, S. D., Flórez‐Grau, G., de Vries, I. J. M., & Hato, S. V. (2019) · Journal of Immunology Research · doi:10.1155/2019/7458238 · Cited by 11
Horikawa, I., Michishita, E., & Barrett, J. C. (2004) · Cytotechnology · doi:10.1007/s10616-004-5122-4 · Cited by 10
Telomerase Inhibitors and Activators: Pharmaceutical Importance
Mutlu, A. G. (2017) · InTech eBooks · doi:10.5772/65933 · Cited by 8
MDS shows a higher expression of hTERT and alternative splice variants in unactivated T-cells
Dong, W., Wu, L., Sun, H., Ren, X., Epling‐Burnette, P. K., & Yang, L. (2016) · Oncotarget · doi:10.18632/oncotarget.12115 · Cited by 7
Matsuguma, M., Yujiri, T., Yamamoto, K., Kajimura, Y., Tokunaga, Y., Tanaka, M., Tanaka, Y., Nakamura, Y., & Tanizawa, Y. (2019) · International Journal of Hematology · doi:10.1007/s12185-019-02742-7 · Cited by 7
Metadata
- Authors
- Dratwa, M., Wysoczańska, B., Łacina, P., Kubik, T., & Bogunia-Kubik, K.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-11-19
- Volume
- 11
- Pages
- 589929-589929
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3106117180
- Cited by
- 311
- References
- 204
- FWCI
- 16.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.